Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5353-5362
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5353
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5353
Table 4 Comparison of human immunodeficiency virus+ vs human immunodeficiency virus- patients transplanted for hepatocellular carcinoma
| Series | Pts number | Milan out | Alfa fetoprotein pre-LT | MiV+ | HCC recurrence | Disease free survival (mo) | ||||||
| HIV+ | HIV- | HIV+ | HIV- | HIV+ | HIV- | HIV+ | HIV- | HIV+ | HIV- | HIV+ | HIV- | |
| Di Benedetto et al[48] | 30 | 125 | 26.7% | 43.2% | 157.88 | 327.64 | 23.30% | 16% | 6.7% | 14.4% | 31.7 | 29.8 |
| (1-2882) | (1-22455) | (1.28-68.78) | (0.43-75.79) | |||||||||
| Viber et al[49] | 16 | 58 | 31% | 34% | 16 | 13 | 50% | 43% | 31% | 15% | 27 | 27 |
| (3-7154) | (1-552) | (14-79) | (2-78) | |||||||||
- Citation: Baccarani U, Righi E, Adani GL, Lorenzin D, Pasqualucci A, Bassetti M, Risaliti A. Pros and cons of liver transplantation in human immunodeficiency virus infected recipients. World J Gastroenterol 2014; 20(18): 5353-5362
- URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5353.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5353